Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_assertion type Assertion NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_head.
- NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_assertion description "[Our study shows that treatment with mepolizumab, an agent designed to target eosinophils, can result in corticosteroid-sparing for patients negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_provenance.
- NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_assertion evidence source_evidence_literature NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_provenance.
- NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_assertion SIO_000772 18344568 NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_provenance.
- NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_assertion wasDerivedFrom befree-20140225 NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_provenance.
- NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_assertion wasGeneratedBy ECO_0000203 NP838492.RAIVPyDqKC3yJRz0l7-bIuauLOl6yhf8llGUcYo0Xdtmw130_provenance.